{"id":"https://openalex.org/W7122708142","doi":"https://doi.org/10.2147/ijn.s561111","title":"Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma","display_name":"Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7122708142","doi":"https://doi.org/10.2147/ijn.s561111","pmid":"https://pubmed.ncbi.nlm.nih.gov/41939214","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13049205"},"language":"en","primary_location":{"id":"doi:10.2147/ijn.s561111","doi":"https://doi.org/10.2147/ijn.s561111","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ijn.s561111","pdf_url":null,"source":{"id":"https://openalex.org/S101287785","display_name":"International Journal of Nanomedicine","issn_l":"1176-9114","issn":["1176-9114","1178-2013"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Nanomedicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.2147/ijn.s561111","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122768541","display_name":"Ziyun Cheng","orcid":"https://orcid.org/0000-0001-5188-4465","observed_orcids":["https://orcid.org/0000-0001-5188-4465"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ziyun Cheng","raw_affiliation_strings":["Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-5188-4465","affiliations":[{"raw_affiliation_string":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]},{"raw_affiliation_string":"Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032399604","display_name":"Mohamadreza Amin","orcid":"https://orcid.org/0000-0002-7520-410X","observed_orcids":["https://orcid.org/0000-0002-7520-410X"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mohamadreza Amin","raw_affiliation_strings":["Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047727639","display_name":"Mandy van Brakel","orcid":"https://orcid.org/0000-0001-9679-1094","observed_orcids":["https://orcid.org/0000-0001-9679-1094"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mandy van Brakel","raw_affiliation_strings":["Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052116403","display_name":"Andrea Sacchetti","orcid":"https://orcid.org/0000-0001-9319-2205","observed_orcids":["https://orcid.org/0000-0001-9319-2205"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Andrea Sacchetti","raw_affiliation_strings":["Department of Pathology, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-9319-2205","affiliations":[{"raw_affiliation_string":"Department of Pathology, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083023579","display_name":"Robbert Q. Kim","orcid":"https://orcid.org/0000-0003-1834-8673","observed_orcids":["https://orcid.org/0000-0003-1834-8673"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Robbert Kim","raw_affiliation_strings":["Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0003-1834-8673","affiliations":[{"raw_affiliation_string":"Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088483921","display_name":"Ann L.B. Seynhaeve","orcid":"https://orcid.org/0000-0002-7389-3597","observed_orcids":["https://orcid.org/0000-0002-7389-3597"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ann Seynhaeve","raw_affiliation_strings":["Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069775632","display_name":"Reno Debets","orcid":"https://orcid.org/0000-0002-3649-807X","observed_orcids":["https://orcid.org/0000-0002-3649-807X"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Reno Debets","raw_affiliation_strings":["Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-3649-807X","affiliations":[{"raw_affiliation_string":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085241723","display_name":"Timo L.M. ten Hagen","orcid":"https://orcid.org/0000-0002-0955-7740","observed_orcids":["https://orcid.org/0000-0002-0955-7740"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Timo ten Hagen","raw_affiliation_strings":["Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-0955-7740","affiliations":[{"raw_affiliation_string":"Precision Medicine in Oncology (PrMiO) and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5085241723"],"corresponding_institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01676169,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 21","issue":null,"first_page":"1","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6729000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6729000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.3125,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.9539999961853027},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9480000138282776},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.8180000185966492},{"id":"https://openalex.org/keywords/binding-avidity","display_name":"binding avidity","score":0.843999981880188},{"id":"https://openalex.org/keywords/ligand-density","display_name":"ligand density","score":0.9300000071525574},{"id":"https://openalex.org/keywords/tumor-retention","display_name":"tumor retention","score":0.699999988079071},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.5799999833106995},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.46399998664855957},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.6159999966621399},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.5699999928474426},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.492000013589859},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.6370000243186951},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C179223381","wikidata":"https://www.wikidata.org/wiki/Q419425","display_name":"Avidity","level":3,"score":0.6887999773025513},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.65829998254776},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6294999718666077},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6050999760627747},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.5827000141143799},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5803999900817871},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5605000257492065},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5299999713897705},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46790000796318054},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44269999861717224},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.42890000343322754},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.42239999771118164},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3889999985694885},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.37599998712539673},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.364300012588501},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3427000045776367},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.3409000039100647},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3172000050544739},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.30799999833106995},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30309998989105225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3018999993801117},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.30160000920295715},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.28999999165534973},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.28780001401901245},{"id":"https://openalex.org/C28005876","wikidata":"https://www.wikidata.org/wiki/Q189814","display_name":"Endocytosis","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2779637612","wikidata":"https://www.wikidata.org/wiki/Q2354337","display_name":"Phosphatidylserine","level":4,"score":0.2858999967575073},{"id":"https://openalex.org/C2778106830","wikidata":"https://www.wikidata.org/wiki/Q29548","display_name":"Cell membrane","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.28290000557899475},{"id":"https://openalex.org/C2779712033","wikidata":"https://www.wikidata.org/wiki/Q28208841","display_name":"Dissociation rate","level":3,"score":0.2824999988079071},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27970001101493835},{"id":"https://openalex.org/C2780405999","wikidata":"https://www.wikidata.org/wiki/Q3483597","display_name":"Co-stimulation","level":5,"score":0.27410000562667847},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.27149999141693115},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.2705000042915344},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.2685000002384186},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.265500009059906},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.26179999113082886},{"id":"https://openalex.org/C201399114","wikidata":"https://www.wikidata.org/wiki/Q898401","display_name":"Lipophilicity","level":2,"score":0.25029999017715454}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.2147/ijn.s561111","doi":"https://doi.org/10.2147/ijn.s561111","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ijn.s561111","pdf_url":null,"source":{"id":"https://openalex.org/S101287785","display_name":"International Journal of Nanomedicine","issn_l":"1176-9114","issn":["1176-9114","1178-2013"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Nanomedicine","raw_type":"journal-article"},{"id":"pmid:41939214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41939214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of nanomedicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13049205","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13049205/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Nanomedicine","raw_type":"Text"},{"id":"pmh:oai:pure.eur.nl:openaire/69021400-c64b-4b60-b12a-744670b73f5a","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/69021400-c64b-4b60-b12a-744670b73f5a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cheng, Z, Amin, M, van Brakel, M, Sacchetti, A, Kim, R Q, Seynhaeve, A L B, Debets, R & ten Hagen, T L M 2026, 'Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma', International Journal of Nanomedicine, vol. 21, pp. 1-22. https://doi.org/10.2147/IJN.S561111","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:76e8303f4220416e8e95a07b18e4d3ee","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/76e8303f4220416e8e95a07b18e4d3ee","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Nanomedicine, Vol Volume 21, Iss Issue 1, Pp 1-22 (2026)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/110882","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/multivalent-atezolizumab-liposome-conjugates-as-active-immunotherapeut-peer-reviewed-fulltext-article-IJN","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ijn.s561111","doi":"https://doi.org/10.2147/ijn.s561111","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ijn.s561111","pdf_url":null,"source":{"id":"https://openalex.org/S101287785","display_name":"International Journal of Nanomedicine","issn_l":"1176-9114","issn":["1176-9114","1178-2013"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Nanomedicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W175405548","https://openalex.org/W1435076864","https://openalex.org/W1517726421","https://openalex.org/W1971062009","https://openalex.org/W1977420748","https://openalex.org/W2010121426","https://openalex.org/W2014262451","https://openalex.org/W2021755139","https://openalex.org/W2037248548","https://openalex.org/W2044568975","https://openalex.org/W2052062569","https://openalex.org/W2096406493","https://openalex.org/W2121887447","https://openalex.org/W2122700509","https://openalex.org/W2126375207","https://openalex.org/W2172105255","https://openalex.org/W2187976253","https://openalex.org/W2257201584","https://openalex.org/W2296051580","https://openalex.org/W2578528809","https://openalex.org/W2747016053","https://openalex.org/W2780310856","https://openalex.org/W2909432292","https://openalex.org/W2914044404","https://openalex.org/W2924982266","https://openalex.org/W2998356375","https://openalex.org/W2998882776","https://openalex.org/W3004343772","https://openalex.org/W3007337667","https://openalex.org/W3019957468","https://openalex.org/W3033002660","https://openalex.org/W3043703771","https://openalex.org/W3046869151","https://openalex.org/W3108231643","https://openalex.org/W3197265554","https://openalex.org/W3199285563","https://openalex.org/W4211168024","https://openalex.org/W4221082366","https://openalex.org/W4292181683","https://openalex.org/W4307423139","https://openalex.org/W4310377878","https://openalex.org/W4313453413","https://openalex.org/W4328049571","https://openalex.org/W4360810060","https://openalex.org/W4367172069","https://openalex.org/W4382196105","https://openalex.org/W4386127543","https://openalex.org/W4389564127","https://openalex.org/W4392560254","https://openalex.org/W4393397203","https://openalex.org/W4399578568","https://openalex.org/W4400831233","https://openalex.org/W4403395702"],"related_works":["https://openalex.org/W7215090995","https://openalex.org/W4298108955","https://openalex.org/W4386865722","https://openalex.org/W2909432292","https://openalex.org/W3033002660","https://openalex.org/W3049069552","https://openalex.org/W3189490217","https://openalex.org/W3010186562","https://openalex.org/W4200392649","https://openalex.org/W2926373909"],"abstract_inverted_index":{"Purpose:":[0],"Anti-programmed":[1],"death":[2],"ligand-1":[3],"monoclonal":[4],"antibody":[5,57,396],"(anti-PD-L1":[6,77],"mAb)":[7],"therapy":[8],"has":[9],"demonstrated":[10,123],"notable":[11],"clinical":[12],"success.":[13],"However,":[14],"efficacy":[15],"is":[16],"often":[17,310],"limited":[18],"by":[19,79],"transient":[20],"interactions":[21],"at":[22,85],"the":[23,239,255,270,303,517],"tumor-immune":[24],"interface,":[25],"limiting":[26],"sustained":[27],"immune":[28,304,546],"activation.":[29],"To":[30,321],"address":[31],"this,":[32,323],"we":[33,72,324,381,415],"hypothesized":[34],"that":[35,124,202,362],"liposomal":[36,92,276],"delivery":[37,419,438,554],"of":[38,61,102,216,242,254,273,524],"anti-PD-L1":[39,75,82,103,126,157,175,203,225,233,256,267,300,338,550],"mAbs":[40,83],"could":[41,456],"enhance":[42],"therapeutic":[43,100,280],"efficacy.":[44],"Nanosystems":[45],"may":[46,471],"increase":[47],"binding":[48,130,247],"avidity":[49],"and":[50,54,99,114,135,147,183,222,251,284,293,350,376,426,446,487,490,515],"prolong":[51],"cell-surface":[52],"retention,":[53,134,250],"enable":[55],"multivalent":[56,74],"presentation":[58],"through":[59],"conjugation":[60],"multiple":[62,117],"antibodies":[63,281,301,407],"onto":[64,88,366],"a":[65,89,178,184,262,418],"single":[66],"liposome.":[67],"Methods:":[68],"In":[69],"this":[70,274,454,494,529],"study,":[71],"engineered":[73,341,406],"liposomes":[76,342],"LPs)":[78],"conjugating":[80],"FDA-approved":[81],"(atezolizumab)":[84],"varying":[86],"densities":[87],"clinically":[90,525],"relevant":[91],"formulation.":[93],"The":[94,464,522],"biophysical":[95],"properties,":[96],"cellular":[97,138],"interactions,":[98],"potential":[101,427,532],"LPs":[104,127,158,176,204,226],"were":[105],"evaluated":[106],"using":[107,439],"two":[108],"melanoma":[109,283,486],"cell":[110],"line":[111],"models":[112,514],"(BLM":[113],"MZ2Mel43),":[115],"employing":[116],"analytical":[118],"techniques.":[119],"Results:":[120],"Our":[121,259,503],"results":[122],"high-density":[125,156],"exhibited":[128],"superior":[129,206],"avidity,":[131],"prolonged":[132],"membrane":[133],"reduced":[136],"non-specific":[137],"interaction":[139],"with":[140,167,337,403,476],"PD-L1-expressing":[141],"cells":[142,221],"compared":[143,166,171,209],"to":[144,172,210,231,278,318,344,373,390,435,497,519,535],"both":[145],"low-density":[146,168],"non-targeted":[148],"LPs.":[149],"Additionally,":[150],"in":[151,191,214,245,282,314,399,451,512],"3D":[152],"tumor":[153,223,249,444],"spheroid":[154],"models,":[155],"showed":[159],"deeper":[160],"penetration,":[161],"suggesting":[162],"improved":[163,194],"tissue":[164,252],"accessibility":[165],"formulations.":[169],"Moreover,":[170],"free":[173,211,232],"antibodies,":[174],"displayed":[177],"higher":[179],"association":[180],"rate":[181,188],"(k_on)":[182],"significantly":[185],"lower":[186],"dissociation":[187,196],"(k_off),":[189],"resulting":[190],"an":[192,432],"overall":[193],"(lower)":[195],"constant":[197],"(K_D).":[198],"Functional":[199],"assays":[200],"confirmed":[201],"achieved":[205],"PD-L1":[207],"blockade":[208],"antibodies.":[212,234,339,357],"Importantly,":[213,398],"co-cultures":[215],"human":[217,536],"peripheral":[218],"blood":[219],"mononuclear":[220],"cells,":[224,404],"maintained":[227],"immunomodulatory":[228],"activity":[229],"comparable":[230],"Conclusion:":[235],"This":[236,429],"study":[237],"highlights":[238],"critical":[240],"role":[241],"ligand":[243],"density":[244],"enhancing":[246,443],"strength,":[248],"penetration":[253],"LP":[257],"system.":[258],"nanosystem":[260],"offers":[261,466],"promising":[263],"improvement":[264],"over":[265],"conventional":[266],"mAbs,":[268],"supporting":[269],"broader":[271],"application":[272],"modular":[275],"platform":[277,465,496],"other":[279,285,498,520],"solid":[286,488],"tumors.":[287],"Plain":[288],"Language":[289],"Summary:":[290],"Current":[291],"limitations":[292],"our":[294],"approach":[295,434,530],"Cancer":[296],"immunotherapy":[297,437],"drugs":[298,365,384],"like":[299,329],"help":[302],"system":[305,420],"fight":[306],"cancer,":[307],"but":[308],"they":[309],"do":[311],"not":[312],"stay":[313,348],"tumors":[315,345,374,391],"long":[316],"enough":[317],"work":[319,408],"effectively.":[320],"improve":[322,457],"developed":[325],"nanoscale":[326],"lipid-based":[327],"carriers,":[328],"tiny":[330,368],"fat":[331],"bubbles":[332],"(called":[333],"liposomes)":[334],"densely":[335],"coated":[336],"These":[340],"bind":[343,389],"more":[346,353,364,392,477],"effectively,":[347],"longer,":[349],"deliver":[351,382],"treatment":[352,458,474],"precisely":[354],"than":[355,394],"regular":[356,395,413],"Key":[358],"discoveries":[359],"We":[360],"discovered":[361],"packing":[363],"each":[367],"carrier":[369],"makes":[370],"them":[371],"stick":[372],"better":[375],"last":[377],"longer.":[378],"Also,":[379],"how":[380],"these":[383,405,510],"matters":[385],"too\u2014the":[386],"carrier-delivered":[387],"versions":[388],"effectively":[393],"drugs.":[397],"controlled":[400],"lab":[401],"tests":[402],"just":[409],"as":[410,412],"powerfully":[411],"immunotherapy\u2014proving":[414],"have":[416],"created":[417],"without":[421],"sacrificing":[422],"cancer-fighting":[423],"strength.":[424],"Conclusion":[425],"benefits":[428],"research":[430],"introduces":[431],"innovative":[433],"cancer":[436,499,543],"antibody-coated":[440],"liposomes.":[441],"By":[442],"targeting":[445],"retention":[447],"while":[448,460],"minimizing":[449],"accumulation":[450],"healthy":[452],"tissues,":[453],"method":[455],"effectiveness":[459],"reducing":[461],"side":[462],"effects.":[463],"three":[467],"key":[468],"advantages:":[469],"patients":[470],"require":[472],"fewer":[473],"sessions":[475],"durable":[478],"results,":[479],"clinicians":[480],"gain":[481],"enhanced":[482],"options":[483],"for":[484,531],"treating":[485],"tumors,":[489],"researchers":[491],"can":[492],"extend":[493],"adaptable":[495],"therapies.":[500],"Future":[501],"directions":[502],"immediate":[504],"focus":[505],"will":[506],"be":[507],"on":[508],"validating":[509],"findings":[511],"animal":[513],"expanding":[516],"technology":[518],"immunotherapies.":[521],"use":[523],"approved":[526],"components":[527],"positions":[528],"rapid":[533],"translation":[534],"trials,":[537],"pending":[538],"successful":[539],"preclinical":[540],"results.":[541],"Keywords:":[542],"immunotherapy,":[544],"melanoma,":[545],"checkpoint":[547],"inhibitors,":[548],"liposomes,":[549],"mAb,":[551],"targeted":[552],"drug":[553]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-01-13T00:00:00"}